Training to take you through the key stages of system and process auditing, from planning and design to execution and reporting.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationThe MHRA has updated its guidance on modifying clinical trial approvals, introducing Route A and B processes to streamline amendments.
The MHRA has released updated guidance on the use of non-investigational medicinal products (NIMPs) in clinical trials, effective from 28th April 2026.
The MHRA has released updated guidance on labelling requirements for IMPs used in clinical trials, effective from 1st October 2025.
The UK and US regulators have strengthened their partnership to accelerate innovation, enhance patient safety, and reduce market access barriers for medical technologies and AI-driven healthcare solutions.
The UK has reduced clinical trial approval times from 91 to 41 days, enhancing patient access to new treatments.
On 7th October 2025, the World Health Organization (WHO) officially launched the Global Clinical Trials Forum (GCTF), a collaborative network aimed at enhancing clinical trial environments and infrastructure globally.
The UK establishes a National Commission to expedite safe AI integration into the NHS.
The FDA has released final guidance to streamline software assurance in medical device manufacturing.
Now Available
The MHRA reflects on its future priorities to strengthen healthcare regulation and innovation.